Literature DB >> 11485338

Osteoporosis in men.

I Pande1, R M Francis.   

Abstract

Osteoporosis is characterized by a reduction in bone density, associated with skeletal fragility and an increased risk of fracture after minimal trauma. Although osteoporosis is generally considered to be a condition affecting post-menopausal women, it is now clear that substantial bone loss occurs with advancing age in men, such that up to 20% of symptomatic vertebral fractures and 30% of hip fractures occur in men. This chapter highlights the incidence and prevalence of osteoporotic fractures in men and reviews the associated morbidity, excess mortality and health and social service expenditure. The determinants of peak bone mass and bone loss in men are discussed, as is the pathogenesis of osteoporosis and vertebral and hip fractures. The criteria for the diagnosis of osteoporosis in men are reviewed, together with the most appropriate investigations for secondary osteoporosis. The management of osteoporosis in men is also discussed, highlighting the most appropriate treatment options. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11485338     DOI: 10.1053/berh.2001.0158

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  6 in total

1.  Older men's explanatory model for osteoporosis.

Authors:  Samantha L Solimeo; Thomas J Weber; Deborah T Gold
Journal:  Gerontologist       Date:  2011-02-10

2.  Quality of life, morbidity, and mortality after low trauma hip fracture in men.

Authors:  I Pande; D L Scott; T W O'Neill; C Pritchard; A D Woolf; M J Davis
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

3.  Osteoporosis screening for men: are family physicians following the guidelines?

Authors:  Natalie Cheng; Michael E Green
Journal:  Can Fam Physician       Date:  2008-08       Impact factor: 3.275

4.  Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density.

Authors:  K Hayashi; M Yamamoto; Y Murakawa; M Yamauchi; H Kaji; T Yamaguchi; T Sugimoto
Journal:  Osteoporos Int       Date:  2009-04-22       Impact factor: 4.507

Review 5.  Osteoporosis in the aging male: treatment options.

Authors:  Stephen P Tuck; Harish K Datta
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

6.  Parenteral oestrogen in the treatment of prostate cancer: a systematic review.

Authors:  G Norman; M E Dean; R E Langley; Z C Hodges; G Ritchie; M K B Parmar; M R Sydes; P Abel; A J Eastwood
Journal:  Br J Cancer       Date:  2008-02-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.